Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles.

The binding of human factor XII and prekallikrein to vesicles of various compositions and the relationship to activation of factor XII were studied. Factor XII, factor XIIa, and the 40-kilodalton binding fragment of factor XII bound tightly to all of the negatively charged lipids investigated, including sulfatide, phosphatidylserine, and phosphatidylethanolamine, but not to the neutral lipid phosphatidylcholine. Binding could be reversed by high salt, and the dissociation constant for binding to sulfatide vesicles was in the nanomolar range at an ionic strength of 0.15 M. Prekallikrein did not bind significantly to either sulfatide or phosphatidylethanolamine vesicles under the conditions used. Stopped-flow studies showed that the association rate for the factor XII-sulfatide interaction was biphasic and very rapid; the faster rate corresponded to about 30% collisional efficiency. The kinetics of activation of factor XII was investigated and was in agreement with previous studies; sulfatide promoted activation but phosphatidylserine, phosphatidylethanolamine, and phosphatidylcholine did not. Autoactivation rates correlated closely with the packing density of factor XII and factor XIIa on the vesicle surface. In contrast, kallikrein activation of factor XII correlated with the amount of sulfatide-bound factor XII and was relatively insensitive to the density of factor XII on the vesicle surface. When the concentration of factor XII was reduced to only several molecules per vesicle, the autoactivation rate dropped very low whereas kallikrein activation held relatively constant. These results indicated that the autoactivation and the kallikrein activation of factor XII were dependent on different properties of the surface component.

[1]  E. L. Kean Rapid, sensitive spectrophotometric method for quantitative determination of sulfatides. , 1968, Journal of lipid research.

[2]  V. Bloomfield,et al.  Quasi-elastic laser light scattering. , 1978, Methods in enzymology.

[3]  L. Stryer,et al.  Fluorescent probes of biological membranes. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Griffin,et al.  Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor). , 1983, The Journal of biological chemistry.

[5]  M. Silverberg,et al.  Activation of the classical pathway of complement by Hageman factor fragment , 1981, The Journal of experimental medicine.

[6]  R. Waldmann,et al.  Fitzgerald Trait DEFICIENCY OF A HITHERTO UNRECOGNIZED AGENT , FITZGERALD FACTOR , PARTICIPATING IN SURFACE-MEDIATED REACTIONS OF CLOTTING , FIBRINOLYSIS , GENERATION OF KININS , AND THE PROPERTY OF DILUTED PLASMA ENHANCING VASCULAR PERMEABILITY ( PF / DIL ) , 2022 .

[7]  K. Wuepper PREKALLIKREIN DEFICIENCY IN MAN , 1973, The Journal of experimental medicine.

[8]  Kaplan Ap,et al.  A pre-albumin activator of prekallikrein. , 1970, Journal of immunology.

[9]  P. Lee,et al.  Partial purification and characterization of contact activation cofactor. , 1975, The Journal of clinical investigation.

[10]  R. Colman,et al.  Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. , 1977, The Journal of clinical investigation.

[11]  K. Fujikawa,et al.  Mechanism of activation of bovine factor XI by factor XII and factor XIIa. , 1980, Biochemistry.

[12]  V. Bloomfield,et al.  Kinetic and mechanistic analysis of prothrombin-membrane binding by stopped-flow light scattering. , 1982, Biochemistry.

[13]  K. Wuepper,et al.  Flaujeac trait. Deficiency of human plasma kininogen. , 1975, The Journal of clinical investigation.

[14]  J. Griffin,et al.  Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Stoffyn The structure and chemistry of sulfatides , 1966, Journal of the American Oil Chemists' Society.

[16]  J. Griffin,et al.  Recent Advances in The Understanding of Contact Activation Reactions , 2008, Seminars in thrombosis and hemostasis.

[17]  D. Larsson,et al.  Molecular arrangements in glycosphingolipids. , 1972, Chemistry and physics of lipids.

[18]  K. Karlsson,et al.  The identification of sulphatides in human erythrocyte membrane and their relation to sodium-potassium dependent adenosine triphosphatase. , 1978, Journal of biochemistry.

[19]  P. E. Bock,et al.  Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species. , 1981, Biochemistry.

[20]  M. Pusey,et al.  Kinetic and hydrodynamic analysis of blood clotting factor V-membrane binding. , 1982, Biochemistry.

[21]  J. Griffin,et al.  The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. , 1977, The Journal of clinical investigation.

[22]  P. S. Chen,et al.  Microdetermination of Phosphorus , 1956 .

[23]  K. Fujikawa,et al.  Activation of bovine factor XII (Hageman factor) by plasma kallikrein. , 1980, Biochemistry.

[24]  K. Fujikawa,et al.  Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor). , 1977, Biochemistry.

[25]  Ching-Hsien Huang,et al.  Phosphatidylcholine vesicles. Formation and physical characteristics , 1969 .

[26]  C. Kluft Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein. , 1978, The Journal of laboratory and clinical medicine.

[27]  J. Dunn,et al.  Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. , 1980, The Journal of biological chemistry.

[28]  J. Griffin Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Hathaway,et al.  Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. , 1965, Blood.

[30]  J. Margolis THE INTERRELATIONSHIP OF COAGULATION OF PLASMA AND RELEASE OF PEPTIDES , 1963, Annals of the New York Academy of Sciences.

[31]  O. Ratnoff,et al.  Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. , 1961, The Journal of clinical investigation.

[32]  O. Ratnoff,et al.  A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. , 1955, The Journal of clinical investigation.

[33]  R. Colman,et al.  Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. , 1975, The Journal of clinical investigation.

[34]  J. Dunn,et al.  The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein. , 1982, The Journal of biological chemistry.

[35]  R. Rosenthal,et al.  New Hemophilia-like Disease Caused by Deficiency of a Third Plasma Thromboplastin Factor.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[36]  A. Bangham,et al.  Membrane models with phospholipids. , 1968, Progress in biophysics and molecular biology.